CVS Health Corp

More Details of CVS Health Corp Company

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.

Company Info

Ticker SymbolCVS

Company nameCVS Health Corp

IPO dateOct 01, 1952

Founded at1996

CEOMr. J. David Joyner

Number of employees300000

Security typeOrdinary Share

Fiscal year-endOct 01

Address1 Cvs Dr

CityWOONSOCKET

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code02895-6146

Phone14017651500

Websitehttps://cvshealth.com/

Ticker SymbolCVS

IPO dateOct 01, 1952

Founded at1996

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Larry Robbins

Independent Director

11.95M

--

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

60.01K

+48.50%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.91K

+0.31%

Mr. Steven H. Nelson

Executive Vice President and President - Aetna

21.33K

--

Mr. Guy P. Sansone

Independent Director

12.01K

+15.04%

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

4.28K

+94.41%

Ms. Leslie V. Norwalk

Director

4.28K

+94.41%

Mr. Roger N. Farah

Executive Chairman of the Board

4.12K

-92.40%

Ms. Alecia A. DeCoudreaux, J.D.

Independent Director

2.97K

--

Dr. Amy L. Compton-Phillips, M.D.

Executive Vice President and Chief Medical Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Larry Robbins

Independent Director

11.95M

--

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

60.01K

+48.50%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.91K

+0.31%

Mr. Steven H. Nelson

Executive Vice President and President - Aetna

21.33K

--

Mr. Guy P. Sansone

Independent Director

12.01K

+15.04%

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

4.28K

+94.41%

Revenue Breakdown

Currency: USDUpdated: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

By BusinessUSD

Name

Revenue

Proportion

Pharmacy

210.27B

56.40%

Premiums

122.90B

32.96%

Front Store

21.52B

5.77%

Other

15.97B

4.28%

Net investment income(loss)

2.15B

0.58%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy

210.27B

56.40%

Premiums

122.90B

32.96%

Front Store

21.52B

5.77%

Other

15.97B

4.28%

Net investment income(loss)

2.15B

0.58%

Shareholding Stats

Updated: Thu, May 15

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

9.31%

Dodge & Cox

5.81%

Capital World Investors

5.41%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Global Advisors (US)

4.58%

Other

69.76%

Shareholders

Proportion

The Vanguard Group, Inc.

9.31%

Dodge & Cox

5.81%

Capital World Investors

5.41%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Global Advisors (US)

4.58%

Other

69.76%

Shareholder Types

Shareholders

Proportion

Investment Advisor

37.65%

Investment Advisor/Hedge Fund

37.63%

Hedge Fund

3.63%

Research Firm

2.87%

Pension Fund

2.00%

Bank and Trust

1.94%

Sovereign Wealth Fund

1.59%

Individual Investor

1.06%

Insurance Company

0.10%

Other

11.54%

Institutional Shareholding

Updated: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

3733

1.09B

86.51%

+17.94M

2024Q4

3853

1.08B

85.46%

-1.57M

2024Q3

3812

1.05B

83.30%

-34.78M

2024Q2

3834

1.06B

84.02%

-4.44M

2024Q1

3863

1.03B

82.03%

-36.45M

2023Q4

3882

1.05B

81.65%

-1.13M

2023Q3

3770

1.04B

80.61%

-13.78M

2023Q2

3775

1.03B

80.60%

-13.09M

2023Q1

3785

1.03B

80.72%

-44.48M

2022Q4

3767

1.06B

81.84%

-22.75M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

116.76M

9.25%

-239.74K

-0.20%

Dec 31, 2024

Dodge & Cox

70.11M

5.55%

+7.08M

+11.23%

Dec 31, 2024

Capital World Investors

61.04M

4.84%

+12.82M

+26.58%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

60.09M

4.76%

+324.23K

+0.54%

Dec 31, 2024

State Street Global Advisors (US)

56.95M

4.51%

+425.05K

+0.75%

Dec 31, 2024

Geode Capital Management, L.L.C.

27.05M

2.14%

+689.87K

+2.62%

Dec 31, 2024

Capital International Investors

26.67M

2.11%

+1.21M

+4.76%

Dec 31, 2024

Fidelity Management & Research Company LLC

21.14M

1.67%

-697.46K

-3.19%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

18.70M

1.48%

+3.80M

+25.51%

Dec 31, 2024

Related ETFs

Updated: Fri, Jun 6

Name

Proportion

Davis Select US Equity ETF

5.39%

Invesco S&P Ultra Dividend Revenue ETF

4.85%

iShares U.S. Healthcare Providers ETF

4.8%

VanEck Retail ETF

4.3%

Brookstone Value Stock ETF

3.72%

iShares US Consumer Staples ETF

3.7%

Invesco S&P 500 Enhanced Value ETF

3.55%

First Trust Consumer Staples Alphadex Fund

3.51%

Invesco S&P 500 Pure Value ETF

3.32%

PGIM Jennison Focused Value ETF

3.04%

Davis Select US Equity ETF

Proportion5.39%

Invesco S&P Ultra Dividend Revenue ETF

Proportion4.85%

iShares U.S. Healthcare Providers ETF

Proportion4.8%

VanEck Retail ETF

Proportion4.3%

Brookstone Value Stock ETF

Proportion3.72%

iShares US Consumer Staples ETF

Proportion3.7%

Invesco S&P 500 Enhanced Value ETF

Proportion3.55%

First Trust Consumer Staples Alphadex Fund

Proportion3.51%

Invesco S&P 500 Pure Value ETF

Proportion3.32%

PGIM Jennison Focused Value ETF

Proportion3.04%

Dividend

A total of 14.66B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 03, 2025

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025

Jan 23, 2025

Feb 03, 2025

Jan 23, 2025

Sep 19, 2024

CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024

Oct 21, 2024

Nov 01, 2024

Oct 21, 2024

Jul 08, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024

Jul 22, 2024

Aug 01, 2024

Jul 22, 2024

Mar 21, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024

Apr 22, 2024

May 01, 2024

Apr 19, 2024

Dec 06, 2023

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024

Jan 22, 2024

Feb 01, 2024

Jan 19, 2024

Sep 21, 2023

CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 01, 2023

Oct 19, 2023

Jul 07, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Aug 01, 2023

Jul 20, 2023

Mar 16, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023

Apr 21, 2023

May 01, 2023

Apr 20, 2023

Dec 15, 2022

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023

Jan 20, 2023

Feb 01, 2023

Jan 19, 2023

Sep 21, 2022

CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022

Oct 21, 2022

Nov 01, 2022

Oct 20, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

67.460USD

CVS Health Corp

67.460

Overview

Company